Kelly R. Hume

Associate Professor
Clinical Sciences, College of Veterinary Medicine

Contact Information

930 Campus Road, Box 31
Cornell University
Ithaca, NY 14853
p: (607) 253-3516

Kelly R. Hume

Associate Professor
Clinical Sciences, College of Veterinary Medicine

Expertise

Veterinary medical oncology; chemotherapy; DNA damage responses; genomic instability

Current Research Interest

How the DNA damage response gene Hus1 affects lung tumorigenesis and chemosensitivity; DNA damage response proteins as biomarkers of chemosensitivity and therapeutic targets; drug repurposing for affordable cancer therapies

Selected Publications

Bing, Yike, Zacharie Wund, Tina Abratte, Lucia Borlle, Susie Kang, Teresa Southard, and Kelly R. Hume. “Biological Indicators of Chemoresistance: An Ex Vivo Analysis of γH2AX and p53 Expression in Feline Injection Site Sarcoma.” Cancer Cell International 18 (2018):192.

Davis, Lillie L., Kelly R. Hume, and Tracy Stokol. “A Retrospective Review of Acute Myeloid Leukaemia in 35 Dogs Diagnosed by a Combination of Morphologic Findings, Flow Cytometric Immunophenotyping and Cytochemical Staining Results (2007-2015).” Veterinary and Comparative Oncology 16 (2018): 268-275.

Cornell Research Website Article

Cancer Therapy for Pets—Maybe Humans, Too